ID 47 -
Niacyna
PL: Niacyna
EN: Nacin
Pdf: niacin
Oświadczenie (4)
- Niacyna może przyczynić się do zmniejszenia zmęczenia
Oświadczenie (2)
- Niacyna może przyczynić się do zmniejszenia zmęczenia
- sytuacjach braku odpowiednich mikroskładników
1. Charakterystyka żywności / składnika
The food constituent that is the subject of the health claims is niacin, which is a well recognised nutrient and is measurable in foods by established methods.
Preformed niacin occurs naturally in foods either as nicotinamide, as derived pyridine nucleotide coenzymes (nicotinamide adenine dinucleotide, NAD and nicotinamide adenine dinucleotide phosphate, NADP) or as nicotinic acid. Niacin can also be synthesised in the body from dietary tryptophan. Niacin is the common term for nicotinamide and nicotinic acid and is authorised for addition to foods (Annex I of the Regulation (EC) No 1925/20066 and Annex I of Directive 2002/46/EC7). This evaluation applies to niacin naturally present in foods and those forms authorised for addition to foods (Annex II of Regulation (EC) No 1925/2006 and Annex II of Directive 2002/46/EC).
The Panel considers that the food constituent, niacin, which is the subject of the health claims is sufficiently characterised.
2.1. Zmniejszenie zmęczenia (ID 47)
The claimed effect is “vitamin/mineral supplementation to reduce fatigue and tiredness in situations of inadequate micronutrient status”. The Panel assumes that the target population is the general population.
The Panel considers that reduction of tiredness and fatigue is a beneficial physiological effect.
3.1. Zmniejszenie zmęczenia (ID 47)
A combined deficiency of niacin and tryptophan causes the classical symptoms of pellagra. The clinical features of pellagra are dermatitis, diarrhoea and dementia. Symptoms also include depression, apathy, headache, fatigue and loss of memory (Jacob, 2006; EVM, 2002; IoM, 2000).
The Panel concludes that a cause and effect relationship has been established between the dietary intake of niacin and reduction of tiredness and fatigue. However, the evidence provided does not establish that inadequate intake of niacin leading to tiredness and fatigue occurs in the general EU population.
4.1. Zmniejszenie zmęczenia (ID 47)
The Panel considers that the following wording reflects the scientific evidence: “Niacin can contribute to the reduction of tiredness and fatigue”.
5. Warunki i możliwe ograniczenia stosowania oświadczenia
The Panel considers that in order to bear the claims a food should be at least a source of niacin as per Annex to Regulation (EC) No 1924/2006. Such amounts can be easily consumed as part of a balanced diet. The target population is the general population. Tolerable Upper Intake Levels (ULs) have been established for free nicotinic acid and nicotinamide (SCF, 2002).
Warunki i możliwe ograniczenia stosowania oświadczenia
Must meet minimum requirements for use of the claim "source of [name of vitamin/s] and/or [name of mineral/s]," as per Annex to Regulation 1924/2006.
Agency guidance for supplements is that products containing >20 mg of nicotinic acid should carry the label advisory statement "[This amount of Nicotinic acid]* may cause skin flushes in sensitive individuals"